Susanne Famulla

1.7k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Susanne Famulla is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Susanne Famulla has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Susanne Famulla's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (7 papers). Susanne Famulla is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (7 papers). Susanne Famulla collaborates with scholars based in Germany, United States and Belgium. Susanne Famulla's co-authors include Henrike Sell, Jürgen Eckel, Sonja Hartwig, Daniela Lamers, Johannes Ruige, D. Margriet Ouwens, Kristin Eckardt, Stefan Lehr, Stefan Müller and Franz‐Georg Hanisch and has published in prestigious journals such as Diabetes Care, Diabetes and International Journal of Obesity.

In The Last Decade

Susanne Famulla

14 papers receiving 1.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

2011 481 citations Daniela Lamers, Susanne Famulla et al. Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susanne Famulla Germany	11	688	385	373	330	294	15	1.4k
Daniela Lamers Germany	11	462 0.7×	256 0.7×	329 0.9×	316 1.0×	259 0.9×	12	1.1k
Xiemin Cao Canada	19	1.4k 2.0×	860 2.2×	313 0.8×	229 0.7×	722 2.5×	24	2.0k
Gemma Pujadas Spain	17	602 0.9×	314 0.8×	201 0.5×	122 0.4×	336 1.1×	27	1.2k
Akio Kawakami Japan	20	482 0.7×	591 1.5×	157 0.4×	303 0.9×	385 1.3×	43	1.5k
Teruo Jojima Japan	18	756 1.1×	412 1.1×	167 0.4×	539 1.6×	355 1.2×	47	1.3k
Meena Asmar Denmark	22	1.2k 1.7×	660 1.7×	297 0.8×	124 0.4×	595 2.0×	32	1.7k
Hiromasa Goto Japan	14	633 0.9×	231 0.6×	219 0.6×	207 0.6×	443 1.5×	35	1.2k
A Casolaro Italy	16	799 1.2×	382 1.0×	220 0.6×	157 0.5×	308 1.0×	26	1.2k
Phil Ambery United Kingdom	18	897 1.3×	399 1.0×	233 0.6×	210 0.6×	449 1.5×	57	1.3k
Elisabeth Widén Finland	22	740 1.1×	625 1.6×	526 1.4×	237 0.7×	922 3.1×	29	2.5k

Countries citing papers authored by Susanne Famulla

Since Specialization

Citations

This map shows the geographic impact of Susanne Famulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Famulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Famulla more than expected).

Fields of papers citing papers by Susanne Famulla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Famulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Famulla. The network helps show where Susanne Famulla may publish in the future.

Co-authorship network of co-authors of Susanne Famulla

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Famulla. A scholar is included among the top collaborators of Susanne Famulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Famulla. Susanne Famulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Andersen, Grit, et al.. (2023). A co‐formulation of pramlintide and insulin A21G ( ADO09 ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 25(5). 1241–1248. 5 indexed citations

Garhyan, Parag, Edward Pratt, Oliver Klein, et al.. (2022). Evaluation of Insulin Lispro Pharmacokinetics and Pharmacodynamics Over 10 Days of Continuous Insulin Infusion in People With Type 1 Diabetes. Journal of Diabetes Science and Technology. 17(2). 274–282.

Andersen, Grit, et al.. (2021). 197-OR: ADO09, a Coformulation of Insulin A21G and Pramlintide (Pram), Improves Blood Glucose Control and Reduces Body Weight in Subjects with T1D. Diabetes. 70(Supplement_1). 1 indexed citations

Andersen, Grit, et al.. (2020). 112-LB: ADO09, a Coformulation of Pramlintide (PRAM) and Insulin A21G, Improves Postprandial Glucose vs. Novolog in Type 1 Diabetes (T1D). Diabetes. 69(Supplement_1). 1 indexed citations

Andersen, Grit, et al.. (2020). ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Diabetes Obesity and Metabolism. 23(4). 961–970. 22 indexed citations

Heise, Tim, et al.. (2017). Insulin degludec: L ower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U / mL in type 1 diabetes. Diabetes Obesity and Metabolism. 19(7). 1032–1039. 95 indexed citations

Famulla, Susanne, Thomas R. Pieber, Dietmar Neubacher, et al.. (2016). Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1). Diabetes Technology & Therapeutics. 19(1). 49–60. 46 indexed citations

Famulla, Susanne, Ulrike Hövelmann, Annelie Fischer, et al.. (2016). Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control. Diabetes Care. 39(9). 1486–1492. 112 indexed citations

Pieber, Thomas R., Susanne Famulla, Nima Soleymanlou, et al.. (2015). Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial ( EASE ‐1). Diabetes Obesity and Metabolism. 17(10). 928–935. 135 indexed citations

10.

Märker, Tina, Henrike Sell, Jennifer Kriebel, et al.. (2012). Heat Shock Protein 60 as a Mediator of Adipose Tissue Inflammation and Insulin Resistance. Diabetes. 61(3). 615–625. 55 indexed citations

11.

Famulla, Susanne, Raphaela Schlich, Henrike Sell, & Jürgen Eckel. (2012). Differentiation of human adipocytes at physiological oxygen levels results in increased adiponectin secretion and isoproterenol-stimulated lipolysis. Adipocyte. 1(3). 132–181. 31 indexed citations

12.

Lamers, Daniela, Susanne Famulla, Nina Wronkowitz, et al.. (2011). Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome. Diabetes. 60(7). 1917–1925. 481 indexed citations breakdown →

13.

Famulla, Susanne, A Horrighs, A. Cramer, Henrike Sell, & Jürgen Eckel. (2011). Hypoxia reduces the response of human adipocytes towards TNFα resulting in reduced NF-κB signaling and MCP-1 secretion. International Journal of Obesity. 36(7). 986–992. 41 indexed citations

14.

Lehr, Stefan, Sonja Hartwig, Daniela Lamers, et al.. (2011). Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes. Molecular & Cellular Proteomics. 11(1). M111.010504–M111.010504. 197 indexed citations

15.

Famulla, Susanne, Daniela Lamers, Sonja Hartwig, et al.. (2010). Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. International Journal of Obesity. 35(6). 762–772. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact